These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8974572)
1. [The biochemical mechanisms of the action of N-alkyl-N-nitrosoureas. The possible reasons for drug resistance to these compounds]. Syrkin AB; Gorbacheva LB Eksp Klin Farmakol; 1996; 59(2):69-75. PubMed ID: 8974572 [TBL] [Abstract][Full Text] [Related]
2. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): II. Role of O6-alkylguanine-DNA alkyltransferase in cytotoxicity. Baumann RP; Shyam K; Penketh PG; Remack JS; Brent TP; Sartorelli AC Cancer Chemother Pharmacol; 2004 Apr; 53(4):288-95. PubMed ID: 14685775 [TBL] [Abstract][Full Text] [Related]
3. Inactivation and degradation of O(6)-alkylguanine-DNA alkyltransferase after reaction with nitric oxide. Liu L; Xu-Welliver M; Kanugula S; Pegg AE Cancer Res; 2002 Jun; 62(11):3037-43. PubMed ID: 12036910 [TBL] [Abstract][Full Text] [Related]
4. [The biochemical mechanisms of drug resistance to N-alkyl-N-nitrosoureas and derivatives of cis-dichlorodiammineplatinum]. Gorbacheva LB Vopr Onkol; 1995; 41(2):50-1. PubMed ID: 7483435 [No Abstract] [Full Text] [Related]
5. Adenine-containing DNA-DNA cross-links of antitumor nitrogen mustards. Balcome S; Park S; Quirk Dorr DR; Hafner L; Phillips L; Tretyakova N Chem Res Toxicol; 2004 Jul; 17(7):950-62. PubMed ID: 15257621 [TBL] [Abstract][Full Text] [Related]
6. Reaction of N-(2-chloroethyl)-N-nitrosoureas with DNA: effect of buffers on DNA adduction, cross-linking, and cytotoxicity. Chen FX; Bodell WJ; Liang G; Gold B Chem Res Toxicol; 1996; 9(1):208-14. PubMed ID: 8924592 [TBL] [Abstract][Full Text] [Related]
7. Function of domains of human O6-alkylguanine-DNA alkyltransferase. Fang Q; Kanugula S; Pegg AE Biochemistry; 2005 Nov; 44(46):15396-405. PubMed ID: 16285744 [TBL] [Abstract][Full Text] [Related]
8. DNA-Directed alkylating agents. 7. Synthesis, DNA interaction, and antitumor activity of bis(hydroxymethyl)- and bis(carbamate)-substituted pyrrolizines and imidazoles. Atwell GJ; Fan JY; Tan K; Denny WA J Med Chem; 1998 Nov; 41(24):4744-54. PubMed ID: 9822545 [TBL] [Abstract][Full Text] [Related]
9. Effect of alterations of key active site residues in O6-alkylguanine-DNA Alkyltransferase on its ability to modulate the genotoxicity of 1,2-dibromoethane. Liu L; Watanabe K; Fang Q; Williams KM; Guengerich FP; Pegg AE Chem Res Toxicol; 2007 Jan; 20(1):155-63. PubMed ID: 17226938 [TBL] [Abstract][Full Text] [Related]
11. A new O6-alkylguanine-DNA alkyltransferase inhibitor associated with a nitrosourea (cystemustine) validates a strategy of melanoma-targeted therapy in murine B16 and human-resistant M4Beu melanoma xenograft models. Rapp M; Maurizis JC; Papon J; Labarre P; Wu TD; Croisy A; Guerquin-Kern JL; Madelmont JC; Mounetou E J Pharmacol Exp Ther; 2008 Jul; 326(1):171-7. PubMed ID: 18411412 [TBL] [Abstract][Full Text] [Related]
12. Cellular resistance against the novel hybrid anthracycline N-(2-chloroethyl)-N-nitrosoureidodaunorubicin (AD 312) is mediated by combined altered topoisomerase II and O6-methylguanine-DNA methyltransferase activities. Pawlik CA; Israel M; Sweatman TW; Lothstein L Oncol Res; 1998; 10(4):209-17. PubMed ID: 9778692 [TBL] [Abstract][Full Text] [Related]
13. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents. Dolan ME; McRae BL; Ferries-Rowe E; Belanich M; van Seventer GA; Guitart J; Pezen D; Kuzel TM; Yarosh DB Clin Cancer Res; 1999 Aug; 5(8):2059-64. PubMed ID: 10473086 [TBL] [Abstract][Full Text] [Related]
14. O6-alkylguanine-DNA alkyltransferase has opposing effects in modulating the genotoxicity of dibromomethane and bromomethyl acetate. Liu L; Williams KM; Guengerich FP; Pegg AE Chem Res Toxicol; 2004 Jun; 17(6):742-52. PubMed ID: 15206895 [TBL] [Abstract][Full Text] [Related]
15. DNA sequence context affects repair of the tobacco-specific adduct O(6)-[4-Oxo-4-(3-pyridyl)butyl]guanine by human O(6)-alkylguanine-DNA alkyltransferases. Mijal RS; Kanugula S; Vu CC; Fang Q; Pegg AE; Peterson LA Cancer Res; 2006 May; 66(9):4968-74. PubMed ID: 16651455 [TBL] [Abstract][Full Text] [Related]
16. [Will transfer of cytostatic drug resistance genes increase hematopoiesis resistance in the treatment of malignant tumors?]. JelĂnek J; Fairbairn LJ; Dexter TM; Rafferty JA; Stocking C; Baum C; Ostertag W; Margison GP Cas Lek Cesk; 1997 Jan; 136(1):22-6. PubMed ID: 9147848 [TBL] [Abstract][Full Text] [Related]
17. DNA minor groove targeted alkylating agents based on bisbenzimidazole carriers: synthesis, cytotoxicity and sequence-specificity of DNA alkylation. Smaill JB; Fan JY; Denny WA Anticancer Drug Des; 1998 Dec; 13(8):857-80. PubMed ID: 10335264 [TBL] [Abstract][Full Text] [Related]
18. DNA adducts and the mechanism of carcinogenesis and cytotoxicity of methylating agents of environmental and clinical significance. Kyrtopoulos SA; Anderson LM; Chhabra SK; Souliotis VL; Pletsa V; Valavanis C; Georgiadis P Cancer Detect Prev; 1997; 21(5):391-405. PubMed ID: 9307842 [TBL] [Abstract][Full Text] [Related]
19. Modulating effect of new potential antimelanomic agents, spin-labeled triazenes and nitrosoureas on the DOPA-oxidase activity of tyrosinase. Gadjeva V; Zheleva A; Raikova E Cancer Biochem Biophys; 1999 Jul; 17(1-2):99-108. PubMed ID: 10738906 [TBL] [Abstract][Full Text] [Related]
20. Role of DNA minor groove alkylation and DNA cross-linking in the cytotoxicity of polybenzamide mustards. Turner PR; Denny WA; Ferguson LR Anticancer Drug Des; 2000 Aug; 15(4):245-53. PubMed ID: 11200500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]